Given that pancreatic cancer stemness negatively regulated anti-cancer immunity, we screened out CEACAM5, which was highly expressed in the high mRNAsi score group, among the 37 selected inhibitory immune checkpoint genes (Fig. 2B). Here, CEACAM5 is linked to cancer.